Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor.
Recent studies have identified a series of estrogen receptor (ER)-interacting peptides that recognize sites that are distinct from the classic coregulator recruitment (AF2) region. Here, we report the structural and functional characterization of an ERalpha-specific peptide that binds to the liganded receptor in an AF2-independent manner. The 2-A crystal structure of the ER/peptide complex reveals a binding site that is centered on a shallow depression on the beta-hairpin face of the ligand-binding domain. The peptide binds in an unusual extended conformation and makes multiple contacts with the ligand-binding domain. The location and architecture of the binding site provides an insight into the peptide's ER subtype specificity and ligand interaction preferences. In vivo, an engineered coactivator containing the peptide motif is able to strongly enhance the transcriptional activity of liganded ERalpha, particularly in the presence of 4-hydroxytamoxifen. Furthermore, disruption of this binding surface alters ER's response to the coregulator TIF2. Together, these results indicate that this previously unknown interaction site represents a bona fide control surface involved in regulating receptor activity.
Kong
Eric H
EH
Structural Biology Laboratory, Chemistry Department, University of York, York YO10 5YW, United Kingdom.
Heldring
Nina
N
Gustafsson
Jan-Ake
JA
Treuter
Eckardt
E
Hubbard
Roderick E
RE
Pike
Ashley C W
AC
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D001665:Binding Sites; D004965:Estrogen Antagonists / Q000737:chemistry*; D047628:Estrogen Receptor alpha / Q000737:chemistry*; D008024:Ligands; D008958:Models, Molecular; D008969:Molecular Sequence Data; D014158:Transcription, Genetic
D004965:Estrogen Antagonists; D047628:Estrogen Receptor alpha; D008024:Ligands
J Med Chem. 2002 Jan 31;45(3):584-9
11806710
Nature. 2002 Feb 14;415(6873):813-7
11845213
Chembiochem. 2003 Jan 3;4(1):14-25
12512072
Nature. 1997 Jun 12;387(6634):733-6
9192902
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
15299926
Nature. 1999 Nov 4;402(6757):93-6
10573424
Genes Dev. 1998 Nov 1;12(21):3343-56
9808622
J Biol Chem. 2002 Jun 14;277(24):21862-8
11937504
Cell. 1998 Dec 23;95(7):927-37
9875847
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3999-4004
10097152
Protein Eng. 1995 Feb;8(2):127-34
7630882
Science. 2002 Mar 29;295(5564):2465-8
11923541
Biochemistry. 1997 Dec 2;36(48):14897-905
9398213
J Biol Chem. 2001 Jun 29;276(26):23397-404
11303023
Cell. 1989 Nov 3;59(3):477-87
2805068
Bioconjug Chem. 2001 May-Jun;12(3):406-13
11353539
Science. 1999 Jul 30;285(5428):744-6
10426998
Mol Cell Biol. 2004 Apr;24(8):3445-59
15060164
Nature. 1998 Sep 10;395(6698):137-43
9744270
J Steroid Biochem Mol Biol. 2003 Aug;86(2):143-9
14568565
Methods Enzymol. 1997;276:307-26
27754618
Mol Cell. 2002 Nov;10(5):1019-32
12453411
Science. 2002 Mar 29;295(5564):2380-1
11923515
Mol Cell Biol. 1997 May;17(5):2735-44
9111344
Nature. 1997 Oct 16;389(6652):753-8
9338790
EMBO J. 2001 Nov 1;20(21):6071-83
11689447
Mol Cell Biol. 1999 Dec;19(12):8226-39
10567548
Genes Dev. 1998 Nov 1;12(21):3357-68
9808623
Endocr Rev. 2004 Feb;25(1):45-71
14769827
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16701-6
12481024
Mol Endocrinol. 2002 Aug;16(8):1778-92
12145334
Cell. 2000 Dec 8;103(6):843-52
11136970